Cargando…

AIM2 Inflammasome in Tumor Cells as a Biomarker for Predicting the Treatment Response to Antiangiogenic Therapy in Epithelial Ovarian Cancer Patients

Antiangiogenic therapy, such as bevacizumab (BEV), has improved progression-free survival (PFS) and overall survival (OS) in high-risk patients with epithelial ovarian cancer (EOC) according to several clinical trials. Clinically, no reliable molecular biomarker is available to predict the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Po-Chao, Chao, Tai-Kuang, Chou, Yu-Ching, Yu, Mu-Hsien, Wang, Yu-Chi, Lin, Yi-Hsin, Lee, Yi-Liang, Liu, Li-Chun, Chang, Cheng-Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509490/ https://www.ncbi.nlm.nih.gov/pubmed/34640548 http://dx.doi.org/10.3390/jcm10194529

Ejemplares similares

The combination of aldehyde dehydrogenase 1 (ALDH1) and CD44 is associated with poor outcomes in endometrial cancer
por: Huang, Hsin-Hui, et al.
Publicado: (2018)

A Weakly Supervised Deep Learning Method for Guiding Ovarian Cancer Treatment and Identifying an Effective Biomarker
por: Wang, Ching-Wei, et al.
Publicado: (2022)

Regulatory Cues in Pulmonary Fibrosis—With Emphasis on the AIM2 Inflammasome
por: Tseng, Yu-Hsin, et al.
Publicado: (2023)

Histopathological whole slide image dataset for classification of treatment effectiveness to ovarian cancer
por: Wang, Ching-Wei, et al.
Publicado: (2022)

Integrating the dysregulated inflammasome-based molecular functionome in the malignant transformation of endometriosis-associated ovarian carcinoma
por: Chang, Chia-Ming, et al.
Publicado: (2017)

AIM 2 inflammasomes regulate neuronal morphology and influence anxiety and memory in mice
por: Wu, Pei-Jung, et al.
Publicado: (2016)

Pyruvate Kinase M2 Expression: A Potential Metabolic Biomarker to Differentiate Endometrial Precancer and Cancer that is Associated with Poor Outcomes in Endometrial Carcinoma
por: Lai, Yu-Ju, et al.
Publicado: (2019)

Subsequent Development of Epithelial Ovarian Cancer After Ovarian Surgery for Benign Ovarian Tumor: A Population-Based Cohort Study
por: Huang, Chen-Yu, et al.
Publicado: (2020)

Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells
por: Wang, Yu-Chi, et al.
Publicado: (2013)

AIM2 Inflammasome's First Decade of Discovery: Focus on Oral Diseases
por: Wang, Lufei, et al.
Publicado: (2020)

Roles of AIM2 Gene and AIM2 Inflammasome in the Pathogenesis and Treatment of Psoriasis
por: Wang, Jieyi, et al.
Publicado: (2022)

Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy
por: Jin, Chengwen, et al.
Publicado: (2022)

Ensemble biomarkers for guiding anti‐angiogenesis therapy for ovarian cancer using deep learning
por: Wang, Ching‐Wei, et al.
Publicado: (2023)

FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells
por: Chiu, Wen-Tai, et al.
Publicado: (2014)

Antiangiogenic drugs in ovarian cancer
por: Kumaran, G C, et al.
Publicado: (2009)

Antiangiogenic therapies in ovarian cancer
por: Reinthaller, Alexander
Publicado: (2016)

Long-range hydrogen-bond relay catalyses the excited-state proton transfer reaction
por: Chang, Kai-Hsin, et al.
Publicado: (2023)

Therapeutic effect of simultaneous intravitreal dexamethasone and aflibercept on diabetic macular edema
por: Lin, Tai-Chi, et al.
Publicado: (2021)

Antiangiogenic drugs used with chemotherapy for patients with recurrent ovarian cancer: a meta-analysis
por: Yi, SuYi, et al.
Publicado: (2017)

Ovarian cancer stem-like cells with induced translineage-differentiation capacity and are suppressed by alkaline phosphatase inhibitor
por: Liu, Kuei-Chun, et al.
Publicado: (2013)

Inflammasome-independent functions of AIM2
por: Zhao, Junjie, et al.
Publicado: (2021)

The Incidence of Bacteremia and Risk Factors of Post-Radiofrequency Ablation Fever for Patients with Hepato-Cellular Carcinoma
por: Chen, Po-Yueh, et al.
Publicado: (2021)

Antiangiogenic Polyketides from Peperomia dindygulensis Miq
por: Wang, Qi-Wei, et al.
Publicado: (2012)

Interaction between HCMV pUL83 and human AIM2 disrupts the activation of the AIM2 inflammasome
por: Huang, Yuan, et al.
Publicado: (2017)

AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA
por: Fernandes-Alnemri, Teresa, et al.
Publicado: (2009)

The Role of AIM2 Inflammasome in Knee Osteoarthritis
por: Yang, Jiyong, et al.
Publicado: (2022)

Key Immunological Functions Involved in the Progression of Epithelial Ovarian Serous Carcinoma Discovered by the Gene Ontology-Based Immunofunctionome Analysis
por: Chang, Cheng-Chang, et al.
Publicado: (2018)

Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma
por: Liu, Nien-Tzu, et al.
Publicado: (2021)

Plate-like Alginate Microparticles with Disulfiram–SPIO–Coencapsulation: An In Vivo Study for Combined Therapy on Ovarian Cancer
por: Bai, Meng-Yi, et al.
Publicado: (2021)

Neutrophil Extracellular Traps Augmented Alveolar Macrophage Pyroptosis via AIM2 Inflammasome Activation in LPS-Induced ALI/ARDS
por: Li, Haitao, et al.
Publicado: (2021)

Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer
por: Lin, Chi-Kang, et al.
Publicado: (2016)

The AIM2 inflammasome is critical for innate immunity against Francisella tularensis
por: Fernandes-Alnemri, Teresa, et al.
Publicado: (2010)

Novel Colorectal Endoscopic Submucosal Dissection With Double-Endoscope and Snare-Based Traction
por: Chou, Chu-Kuang, et al.
Publicado: (2022)

The Risk of Epithelial Ovarian Cancer of Women With Endometriosis May be Varied Greatly if Diagnostic Criteria Are Different: A Nationwide Population-Based Cohort Study
por: Lee, Wen-Ling, et al.
Publicado: (2015)

Robotic Hysterectomy with Ureter Identification and Uterine Artery Ligation for Benign Gynecological Conditions: An Early-Year Single-Center Experience
por: Lee, Yi-Liang, et al.
Publicado: (2023)

An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis
por: Wang, Kuan-Chin, et al.
Publicado: (2014)

Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
por: Chen, Wei-Chun, et al.
Publicado: (2022)

Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patients
por: Lu, Hsiao-Yun, et al.
Publicado: (2020)

BAFF-driven NLRP3 inflammasome activation in B cells
por: Lim, Ken-Hong, et al.
Publicado: (2020)

Are antiangiogenics a good ‘partner’ for immunotherapy in ovarian cancer?
por: García-Martínez, Elena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_enba8dh9gtq3d6tiif04ucskmb